Insider Transactions in Q1 2026 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
Christopher Causey |
SELL
Open market or private sale
|
Direct |
1,000
-19.27%
|
$510,000
$510.0 P/Share
|
|
Jan 06
2026
|
Christopher Causey |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+16.16%
|
$119,000
$119.76 P/Share
|
|
Jan 05
2026
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
22,500
-24.66%
|
$10,957,500
$487.64 P/Share
|
|
Jan 05
2026
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
22,500
+50.0%
|
$2,947,500
$131.9 P/Share
|
|
Jan 05
2026
|
Jan Malcolm |
SELL
Open market or private sale
|
Direct |
50
-11.9%
|
$24,750
$495.01 P/Share
|
|
Jan 02
2026
|
Christopher Causey |
SELL
Open market or private sale
|
Direct |
1,000
-19.27%
|
$500,000
$500.01 P/Share
|
|
Jan 02
2026
|
Christopher Causey |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+16.16%
|
$119,000
$119.76 P/Share
|
|
Jan 02
2026
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
8,300
-2.5%
|
$4,025,500
$485.05 P/Share
|
|
Jan 02
2026
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,300
+15.55%
|
$1,211,800
$146.03 P/Share
|